SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

Share Price is delayed by 15 minutes
Get Live Data
4,540.00    90.00 (2.02%)
Bid:
4,500.00
Ask:
4,580.00
Spread: 80.00 (1.778%)
Market Cap: £302.40m
JDG Live PriceLast checked at - London Stock Exchange

Intraday Judges Scientific Share Chart

Trading Statement

20 Jul 2009 07:00

RNS Number : 8714V
Judges Scientific PLC
20 July 2009
 

Judges Scientific plc

("Judges Scientific", the "Company" or the "Group")

Trading Statement

20 July 2009

Judges Scientific, the parent company of a group that specialises in the design, manufacture and sale of scientific instruments, is pleased to announce a trading update in respect of the six months ended 30 June 2009.

The announcement last March of the Company's results for the year ended 31 December 2008 included the disclosure that the sales order book had reached a record level at the end of that year and explained that currency movements during the reporting period were having a positive influence on the Company's business.

The Board is now in a position to confirm that these favourable factors have enabled the Group to trade strongly in the first half of the financial year and that this is expected to result in an encouraging improvement in adjusted earnings per share for the period (calculated before amortisation of intangible assets). This progress will have been achieved despite 10 per cent increase in the average number of shares in issue during the period and a modest recovery in SterlingIt should be noted, however, that the results benefited from a maiden three-week contribution from the newly acquired Quorum Technologies Ltd. 

Order intake during the first half of 2009 showed a healthy increase over the figure achieved during the first six months of 2008. The sales order book as at 30 June 2009 stood well below the level on hand at the start of the year but well above the level as at 30 June 2008. These comparisons are on a like-for-like basis, excluding the effects of the acquisition of Quorum.

The Board remains cautiously optimistic in respect of the second half of the financial year, which will enjoy a full six-month contribution from Quorum Technologies, while recognising the possibility that adverse foreign exchange movements and/or the effects of the general economic downturn may yet offset some of these positive developments.

Ends

Enquiries:

Judges Scientific plc

David Cicurel, CEO

01342 323 600

Shore Capital

Pascal Keane

020 7408 4090

Cardew Group

Melvyn Marckus

07775 896491

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGGGMNMNNGLZM
Date   Source Headline
6th Apr 20232:50 pmRNSDirector/PDMR Shareholding
4th Apr 202312:21 pmRNSTotal Voting Rights
3rd Apr 20237:01 amRNSAcquisition of Henniker Scientific Limited
3rd Apr 20237:00 amRNSAppointment of Joint Broker
31st Mar 20238:54 amRNSGrant of Options
22nd Mar 20237:00 amRNSFinal Results
8th Mar 20232:39 pmRNSTotal Voting Rights
8th Mar 20237:00 amRNSDirector/PDMR Shareholding
13th Feb 20238:48 amRNSDirector/PDMR Shareholding
2nd Feb 20239:17 amRNSDirector/PDMR Shareholding
1st Feb 20237:00 amRNSExecutive Director and Board Appointment
1st Feb 20237:00 amRNSTotal Voting Rights
23rd Jan 202310:27 amRNSGrant of Options
19th Jan 20237:00 amRNSFull Year Trading Statement and Notice of Results
9th Jan 20237:00 amRNSDirector/PDMR Shareholding
3rd Jan 20231:03 pmRNSTotal Voting Rights
21st Dec 202210:51 amRNSBlock listing Interim Review
20th Dec 202211:53 amRNSDirector/PDMR Shareholding
12th Dec 20228:52 amRNSHolding(s) in Company
6th Dec 20222:34 pmRNSDirector/PDMR Shareholding
1st Dec 202210:01 amRNSTotal Voting Rights
30th Nov 20224:41 pmRNSSecond Price Monitoring Extn
30th Nov 20224:35 pmRNSPrice Monitoring Extension
17th Nov 20228:54 amRNSDirector/PDMR Shareholding
7th Nov 20225:14 pmRNSDirector/PDMR Shareholding
7th Oct 20227:00 amRNSDirector/PDMR Shareholding
4th Oct 20223:55 pmRNSDirector/PDMR Shareholding
3rd Oct 202210:01 amRNSTotal Voting Rights
23rd Sep 20223:44 pmRNSDirector/PDMR Shareholding
22nd Sep 20227:00 amRNSInterim Results
6th Sep 20222:51 pmRNSDirector/PDMR Shareholding
2nd Sep 20223:16 pmRNSTotal Voting Rights
9th Aug 20229:20 amRNSDirector/PDMR Shareholding
1st Aug 202211:07 amRNSTotal Voting Rights
27th Jul 20224:08 pmRNSDirector/PDMR Shareholding
25th Jul 20227:00 amRNSHalf Year Trading Update and Notice of Results
8th Jul 20228:12 amRNSDirector/PDMR Shareholding
1st Jul 20225:34 pmRNSTotal Voting Rights
29th Jun 202211:13 amRNSDirector/PDMR Shareholding
27th Jun 20227:00 amRNSAcquisition of minority shareholding in Bordeaux
21st Jun 20227:00 amRNSDirector/PDMR Shareholding
10th Jun 202211:43 amRNSBlocklisting Return
9th Jun 202212:11 pmRNSDirector/PDMR Shareholding
9th Jun 20227:36 amRNSIssue of Shares – Replacement
8th Jun 20223:52 pmRNSIssue of Ordinary Shares
6th Jun 20223:00 pmRNSPurchase of Ordinary Shares
1st Jun 202212:48 pmRNSTotal Voting Rights
27th May 20221:08 pmRNSAppointment of auditor
24th May 20222:12 pmRNSResult of AGM
23rd May 202211:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.